Pressure BioSciences, Inc. (PBIO)

Pressure BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1.98	1.98	1.73	2	1.22	1.81
Revenue Growth (YoY)	14.36%	14.36%	-13.63%	64.05%	-32.56%	-26.36%
Cost of Revenue	1.59	1.18	2.01	0.94	0.58	1.2
Gross Profit	0.39	0.8	-0.28	1.06	0.64	0.61
Selling, General & Admin	8.94	8.94	3.64	4.14	4.08	5.26
Research & Development	1.37	1.37	0.97	1.1	1.14	1.16
Other Operating Expenses	0.01	0	0.01	0	0	0
Operating Expenses	10.3	10.3	4.61	5.25	5.22	6.42
Operating Income	-9.92	-9.5	-4.9	-4.19	-4.59	-5.81
Interest Income	9.77	0	10.44	14.45	8.34	5.28
Interest Expense	6.9	-15,581.44	10.44	14.45	8.34	5.28
Other Expense / Income	17.05	15,601	11.18	15.97	11.42	6.07
Pretax Income	-29.95	-29.31	-16.08	-20.15	-16.01	-11.88
Income Tax	6,379	-0	0.75	14.45	8.34	-0.22
Net Income	-6,403.12	-29.31	-16.82	-34.6	-24.35	-11.66
Shares Outstanding (Basic)	32	23	11	7	3	2
Shares Outstanding (Diluted)	32	23	11	7	3	2
Shares Change	145.83%	111.03%	66.63%	100.85%	66.24%	29.82%
EPS (Basic)	-403.76	-1.26	-1.52	-5.21	-7.37	-5.87
EPS (Diluted)	-403.76	-1.26	-1.52	-5.21	-7.37	-5.87
Free Cash Flow	-3.19	-3.19	-4.5	-4.99	-4.88	-6.35
Free Cash Flow Per Share	-0.10	-0.14	-0.41	-0.75	-1.48	-3.20
Gross Margin	19.54%	40.43%	-16.46%	52.94%	52.25%	33.86%
Operating Margin	-501.39%	-480.51%	-283.25%	-209.01%	-375.70%	-320.75%
Profit Margin	-323755.75%	-1482.19%	-972.88%	-1728.14%	-1994.92%	-644.25%
Free Cash Flow Margin	-161.47%	-161.47%	-260.14%	-249.28%	-400.20%	-350.88%
EBITDA	-9.83	-9.39	-4.77	-4.08	-4.46	-5.68
EBITDA Margin	-496.91%	-474.82%	-275.86%	-203.51%	-365.27%	-313.70%
Depreciation & Amortization	0.11	0.11	0.12	0.11	0.13	0.12
EBIT	-9.94	-9.5	-4.89	-4.19	-4.59	-5.8
EBIT Margin	-502.60%	-480.51%	-282.79%	-209.01%	-375.70%	-320.53%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.